Cargando…

Hematologic malignancies in South Africa 2000–2006: analysis of data reported to the National Cancer Registry

Little is known about the incidence patterns of hematologic malignancies in Sub‐Saharan Africa, including South Africa. We estimated incidence rates of pathology‐confirmed adult cases of leukemia, myeloma and related diseases (myeloma), Hodgkin lymphoma (HL), and non‐Hodgkin lymphoma (NHL) reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Schonfeld, Sara J., Erdmann, Friederike, Wiggill, Tracey, Singh, Elvira, Kellett, Patricia, Babb, Chantal, Schüz, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831292/
https://www.ncbi.nlm.nih.gov/pubmed/26773310
http://dx.doi.org/10.1002/cam4.597
_version_ 1782427045475647488
author Schonfeld, Sara J.
Erdmann, Friederike
Wiggill, Tracey
Singh, Elvira
Kellett, Patricia
Babb, Chantal
Schüz, Joachim
author_facet Schonfeld, Sara J.
Erdmann, Friederike
Wiggill, Tracey
Singh, Elvira
Kellett, Patricia
Babb, Chantal
Schüz, Joachim
author_sort Schonfeld, Sara J.
collection PubMed
description Little is known about the incidence patterns of hematologic malignancies in Sub‐Saharan Africa, including South Africa. We estimated incidence rates of pathology‐confirmed adult cases of leukemia, myeloma and related diseases (myeloma), Hodgkin lymphoma (HL), and non‐Hodgkin lymphoma (NHL) reported to the National Cancer Registry of South Africa (NCR) between 2000 and2006, by age, gender, and population group (Black, White, Coloured, Asian/Indian). Gender‐specific age‐standardized rates were calculated overall and by population group and incidence rate ratios (IRRs) were estimated using Poisson regression models. Between 2000 and 2006, there were 14662 cases of leukemia, myeloma, HL, and NHL reported to the registry. Incidence rates of reported hematologic malignancies were generally 20–50% higher among males than females. Our analyses suggested marked differences in the rates of reported hematologic malignancies by population group which were most pronounced when comparing the White versus Black population groups (IRRs ranging from 1.6 for myeloma to 3.8 for HL for males and females combined). Challenges related to diagnosis and reporting of cancers may play a role in the patterns observed by population group while the set‐up of the NCR (pathology‐based) could lead to some degree of under‐ascertainment in all groups. This is the first country‐wide report of the incidence of hematologic malignancies in South Africa. Despite challenges, it is important to analyze and report available national cancer incidence data to raise awareness of the cancer burden and to characterize patterns by demographic characteristics so as ultimately to improve the provision of cancer‐related health care.
format Online
Article
Text
id pubmed-4831292
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-48312922016-04-20 Hematologic malignancies in South Africa 2000–2006: analysis of data reported to the National Cancer Registry Schonfeld, Sara J. Erdmann, Friederike Wiggill, Tracey Singh, Elvira Kellett, Patricia Babb, Chantal Schüz, Joachim Cancer Med Cancer Prevention Little is known about the incidence patterns of hematologic malignancies in Sub‐Saharan Africa, including South Africa. We estimated incidence rates of pathology‐confirmed adult cases of leukemia, myeloma and related diseases (myeloma), Hodgkin lymphoma (HL), and non‐Hodgkin lymphoma (NHL) reported to the National Cancer Registry of South Africa (NCR) between 2000 and2006, by age, gender, and population group (Black, White, Coloured, Asian/Indian). Gender‐specific age‐standardized rates were calculated overall and by population group and incidence rate ratios (IRRs) were estimated using Poisson regression models. Between 2000 and 2006, there were 14662 cases of leukemia, myeloma, HL, and NHL reported to the registry. Incidence rates of reported hematologic malignancies were generally 20–50% higher among males than females. Our analyses suggested marked differences in the rates of reported hematologic malignancies by population group which were most pronounced when comparing the White versus Black population groups (IRRs ranging from 1.6 for myeloma to 3.8 for HL for males and females combined). Challenges related to diagnosis and reporting of cancers may play a role in the patterns observed by population group while the set‐up of the NCR (pathology‐based) could lead to some degree of under‐ascertainment in all groups. This is the first country‐wide report of the incidence of hematologic malignancies in South Africa. Despite challenges, it is important to analyze and report available national cancer incidence data to raise awareness of the cancer burden and to characterize patterns by demographic characteristics so as ultimately to improve the provision of cancer‐related health care. John Wiley and Sons Inc. 2016-01-15 /pmc/articles/PMC4831292/ /pubmed/26773310 http://dx.doi.org/10.1002/cam4.597 Text en © 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Prevention
Schonfeld, Sara J.
Erdmann, Friederike
Wiggill, Tracey
Singh, Elvira
Kellett, Patricia
Babb, Chantal
Schüz, Joachim
Hematologic malignancies in South Africa 2000–2006: analysis of data reported to the National Cancer Registry
title Hematologic malignancies in South Africa 2000–2006: analysis of data reported to the National Cancer Registry
title_full Hematologic malignancies in South Africa 2000–2006: analysis of data reported to the National Cancer Registry
title_fullStr Hematologic malignancies in South Africa 2000–2006: analysis of data reported to the National Cancer Registry
title_full_unstemmed Hematologic malignancies in South Africa 2000–2006: analysis of data reported to the National Cancer Registry
title_short Hematologic malignancies in South Africa 2000–2006: analysis of data reported to the National Cancer Registry
title_sort hematologic malignancies in south africa 2000–2006: analysis of data reported to the national cancer registry
topic Cancer Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831292/
https://www.ncbi.nlm.nih.gov/pubmed/26773310
http://dx.doi.org/10.1002/cam4.597
work_keys_str_mv AT schonfeldsaraj hematologicmalignanciesinsouthafrica20002006analysisofdatareportedtothenationalcancerregistry
AT erdmannfriederike hematologicmalignanciesinsouthafrica20002006analysisofdatareportedtothenationalcancerregistry
AT wiggilltracey hematologicmalignanciesinsouthafrica20002006analysisofdatareportedtothenationalcancerregistry
AT singhelvira hematologicmalignanciesinsouthafrica20002006analysisofdatareportedtothenationalcancerregistry
AT kellettpatricia hematologicmalignanciesinsouthafrica20002006analysisofdatareportedtothenationalcancerregistry
AT babbchantal hematologicmalignanciesinsouthafrica20002006analysisofdatareportedtothenationalcancerregistry
AT schuzjoachim hematologicmalignanciesinsouthafrica20002006analysisofdatareportedtothenationalcancerregistry